The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets
The study results provide a framework for understanding the evolution
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading.
CALGARY, Alberta, Aug. 23, 2022 (GLOBE NEWSWIRE) -- DIRTT (or the "Company") (NASDAQ:DRTT, TSX:DRT) announced today the suspension of operations at its manufacturing facility in Rock Hill, South Carolina. WithCALGARY, Alberta, Aug.
KalVista Pharmaceuticals (NASDAQ: KALV) has initiated the KONFIDENT-S open label extension (OLE) study for its ongoing Phase 3 study of sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks.
U.S. stocks closed sharply lower with the Nasdaq Composite dropping more than 300 points on Monday. Here is the list of some big stocks moving higher in the previous session.